HB-EGF induces cardiomyocyte hypertrophy via an ERK5-MEF2A-COX2 signaling pathway

Cellular Signalling

Volumn 23, Issue 7, 2011, Pages 1100-1109

  Lee, Kuy Sook ^a   Park, Jin Hee ^a   Lim, Hyun Joung ^a   Park, Hyun Young ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

Cardiomyocyte hypertrophy; COX 2; HB EGF; MEF2A; MEK5 ERK5

Indexed keywords

ATRIAL NATRIURETIC FACTOR; CYCLOOXYGENASE 2; EPIDERMAL GROWTH FACTOR RECEPTOR; HEPARIN BINDING EPIDERMAL GROWTH FACTOR; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE 7; MITOGEN ACTIVATED PROTEIN KINASE KINASE 5; MYOCYTE ENHANCER FACTOR 2; MYOCYTE ENHANCER FACTOR 2A; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CELL SIZE; CONTROLLED STUDY; ENZYME ACTIVATION; GENE EXPRESSION; GENETIC TRANSFECTION; HEART HYPERTROPHY; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ATRIAL NATRIURETIC FACTOR; CELL ENLARGEMENT; CELL LINE; CYCLOOXYGENASE 2; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MADS DOMAIN PROTEINS; MAP KINASE KINASE 5; MITOGEN-ACTIVATED PROTEIN KINASE 7; MYOCYTES, CARDIAC; MYOGENIC REGULATORY FACTORS; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; RECEPTOR, EPIDERMAL GROWTH FACTOR; RNA INTERFERENCE; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION, GENETIC;

EID: 79954421249     PISSN: 08986568     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cellsig.2011.01.006     Document Type: Article

References (40)

1. Vaughan T.J., Pascall J.C., Brown K.D. Biochem. J. 1992, 287(Pt 3):681.
2. Abraham J.A., Damm D., Bajardi A., Miller J., Klagsbrun M., Ezekowitz R.A. Biochem. Biophys. Res. Commun. 1993, 190:125.
3. Yoshizumi M., Kourembanas S., Temizer D.H., Cambria R.P., Quertermous T., Lee M.E. J. Biol. Chem. 1992, 267:9467.
4. Kennedy T.G., Brown K.D., Vaughan T.J. Endocrinology 1993, 132:1857.
5. Raab G., Klagsbrun M. Biochim. Biophys. Acta 1997, 1333:F179.
6. Perrella M.A., Maki T., Prasad S., Pimental D., Singh K., Takahashi N., Yoshizumi M., Alali A., Higashiyama S., Kelly R.A. J. Biol. Chem. 1994, 269:27045.
7. Jin K., Mao X.O., Del Rio G.G., Jin L., Greenberg D.A. J. Neurosci. Res. 2005, 81:497.
8. Reynolds C.M., Eguchi S., Frank G.D., Motley E.D. Hypertension 2002, 39:525.
9. Shah B.H., Catt K.J. Trends Pharmacol. Sci. 2003, 24:239.
10. Garaude J., Cherni S., Kaminski S., Delepine E., Chable-Bessia C., Benkirane M., Borges J., Pandiella A., Iniguez M.A., Fresno M., Hipskind R.A., Villalba M. J. Immunol. 2006, 177:7607.
11. Lee J.D., Ulevitch R.J., Han J. Biochem. Biophys. Res. Commun. 1995, 213:715.
12. Zhou G., Bao Z.Q., Dixon J.E. J. Biol. Chem. 1995, 270:12665.
13. Hayashi M., Lee J.D. J. Mol. Med. 2004, 82:800.
14. Takahashi N., Saito Y., Kuwahara K., Harada M., Tanimoto K., Nakagawa Y., Kawakami R., Nakanishi M., Yasuno S., Usami S., Yoshimura A., Nakao K. J. Mol. Cell. Cardiol. 2005, 38:185.
15. Nadruz W., Kobarg C.B., Constancio S.S., Corat P.D., Franchini K.G. Circ. Res. 2003, 92:243.
16. Passier R., Zeng H., Frey N., Naya F.J., Nicol R.L., McKinsey T.A., Overbeek P., Richardson J.A., Grant S.R., Olson E.N. J. Clin. Invest. 2000, 105:1395.
17. Molkentin J.D., Markham B.E. J. Biol. Chem. 1993, 268:19512.
18. Kolodziejczyk S.M., Wang L., Balazsi K., DeRepentigny Y., Kothary R., Megeney L.A. Curr. Biol. 1999, 9:1203.
19. Xu K., Shu H.K. Cancer Res. 2007, 67:6121.
20. Rebsamen M.C., Capoccia R., Vallotton M.B., Lang U. J. Mol. Cell. Cardiol. 2003, 35:81.
21. Rocha R., Martin-Berger C.L., Yang P., Scherrer R., Delyani J., McMahon E. Endocrinology 2002, 143:4828.
22. Molero L., Farre J., Garcia-Mendez A., Jimenez Mateos-Caceres P., Carrasco M.C., Millas I., Navarro F., Cordoba M., Casado S., Lopez-Farre A. Cardiovasc. Res. 2003, 57:109.
23. Jacobshagen C., Gruber M., Teucher N., Schmidt A.G., Unsold B.W., Toischer K., Nguyen V.P., Maier L.S., Kogler H., Hasenfuss G. Eur. J. Heart Fail. 2008, 10:334.
24. Streicher J.M., Kamei K., Ishikawa T.O., Herschman H., Wang Y. J. Mol. Cell. Cardiol. 2010, 49:88.
25. Bresalier R.S., Sandler R.S., Quan H., Bolognese J.A., Oxenius B., Horgan K., Lines C., Riddell R., Morton D., Lanas A., Konstam M.A., Baron J.A. N. Engl. J. Med. 2005, 352:1092.
26. Bombardier C., Laine L., Reicin A., Shapiro D., Burgos-Vargas R., Davis B., Day R., Ferraz M.B., Hawkey C.J., Hochberg M.C., Kvien T.K., Schnitzer T.J. N. Engl. J. Med. 2000, 343(1520-8):2.
27. Streicher J.M., Wang Y. Cardiovasc. Hematol. Agents Med. Chem. 2008, 6:69.
28. Wang G.W., Schuschke D.A., Kang Y.J. Am. J. Physiol. 1999, 276:H167.
29. Hannan R.D., Jenkins A., Jenkins A.K., Brandenburger Y. Clin. Exp. Pharmacol. Physiol. 2003, 30:517.
30. Kimura T.E., Jin J., Zi M., Prehar S., Liu W., Oceandy D., Abe J.I., Neyses L., Weston A.H., Cartwright E.J., Wang X. Circ. Res. 2010, 106:961.
31. Sugden P.H. J. Card. Fail. 2002, 8:S359.
32. Wang Y. Circulation 2007, 116:1413.
33. Nakaoka Y., Nishida K., Fujio Y., Izumi M., Terai K., Oshima Y., Sugiyama S., Matsuda S., Koyasu S., Yamauchi-Takihara K., Hirano T., Kawase I., Hirota H. Circ. Res. 2003, 93:221.
34. Nicol R.L., Frey N., Pearson G., Cobb M., Richardson J., Olson E.N. EMBO J. 2001, 20:2757.
35. Cameron S.J., Itoh S., Baines C.P., Zhang C., Ohta S., Che W., Glassman M., Lee J.D., Yan C., Yang J., Abe J. FEBS Lett. 2004, 566:255.
36. Xu J., Gong N.L., Bodi I., Aronow B.J., Backx P.H., Molkentin J.D. J. Biol. Chem. 2006, 281:9152.
37. Wang X., Tournier C. Cell. Signal. 2006, 18:753.
38. Wang X., Merritt A.J., Seyfried J., Guo C., Papadakis E.S., Finegan K.G., Kayahara M., Dixon J., Boot-Handford R.P., Cartwright E.J., Mayer U., Tournier C. Mol. Cell. Biol. 2005, 25:336.
39. Kang Y.J., Mbonye U.R., DeLong C.J., Wada M., Smith W.L. Prog. Lipid Res. 2007, 46:108.
40. Guo Y.S., Cheng J.Z., Jin G.F., Gutkind J.S., Hellmich M.R., Townsend C.M. J. Biol. Chem. 2002, 277:48755.